Brixton Biosciences Nabs $33M to Advance Novel Pain Therapies
Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by...
Stay updated with breaking news from Excelestar Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the...
TiE Global Angels, led by TiE Boston, Invests $1.395M as part of a $20M Investment Round in Sealonix, Inc., a Surgical Sealant Product Company
Sealonix, a biomaterials company, has closed on $20 million in series A funding to develop their next generation of hemostatic sealants for surgical use. The